BTC 
ETH 
BNB 
XRP 
SOL 
TRX Bristol Myers falls on weak Opdivo sales, cut earnings guidance
Investor's Business Daily reported that Bristol Myers Squibb stock dipped early Thursday after lighter-than-expected Opdivo sales and a cut to earnings guidance. The post attributes the decline to those two factors.
Why “Unverified”
- Reported by Investor's Business Daily alone, with no second source or primary confirmation yet
1 independent source group across 1 post · evidence score 52/100. How labels work
What the sources claim
-
Bristol Myers Squibb stock fell early Thursday after Opdivo sales came in below expectations.
“Bristol Myers Squibb stock dipped early Thursday on lighter-than-expected Opdivo sales”
Investor's Business Daily -
Bristol Myers Squibb cut its earnings guidance.
“an earnings guidance haircut”
Investor's Business Daily
Sources
More in Stocks & Indices
Summary and claims extracted by AI with prompt analyze-story@5 on 2026-10-29 13:00 UTC. Labels are computed from the sources, not by the model.